Pharma
0
0
Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound ...
admin
0
0
Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to ...
0
0
A Kura Oncology and Kyowa Kirin-partnered drug vying to become the first FDA-approved treatment for cases of acute myeloid leukemia (AML) carrying ...
Show next
